A Study to Compare Bupivacaine and Levobupivacaine in spinal anesthesia for pregnant patients

Comparative evaluation of the efficacy and safety of INTRATHECAL 0.5% hyperbaric Levobupivacaine with 0.5% hyperbaric Bupivacaine in patients undergoing LSCS under spinal anesthesia - NIL

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/12/077813

Enrollment

Registered

2024-12-06

Start date

Unknown

Completion date

Unknown

Last updated

2024-12-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O60-O77- Complications of labor and delivery

Interventions

Intervention1: SPINAL ANESTHESIA: INTRATHECAL 0.5% hyperbaric Levobupivacaine with 0.5% hyperbaric Bupivacaine in patients undergoing LSCS under spinal anesthesia Intervention2: SPINAL ANETHESIA: Unde

Eligibility

Inclusion criteria

Inclusion criteria: 1.Informed Consent. 2.Pregnant females scheduled to undergo lower segment caesarean section (LSCS) under spinal anesthesia. 3.American Society of Anesthesiologists (ASA) grade I & II. 4.Age 18-35 years

Exclusion criteria

Exclusion criteria: 1.Refusal to give consent. 2.Emergency LSCS. 3.Drug allergy to local anaesthetics / study drugs. 4.ASA grade III and above. 5.AGE less than 18 years or more than 35years. 6.Weight less than 50 Kgs or more than 90Kgs. 7.Height less than 5 feet. 8.Twin /Complicated pregnancy. 9.Any contraindication to regional anesthesia.

Design outcomes

Primary

Measure	Time frame
0.5% hyperbaric Levobupivacaine is better in efficacy and safety in comparison to 0.5% hyperbaric Bupivacaine in LSCS under spinal anesthesia.Timepoint: 24 months	—

Secondary

Measure	Time frame
Is 0.5% hyperbaric Levobupivacaine better in terms of efficacy and safety profile with routinely used drug 0.5% hyperbaric bupivacaine in spinal anesthesia. Timepoint: 24 months	—

Countries

India

Contacts

Public ContactAshish Kumar Sharma

Pacific Medical College and Hospital Udaipur

sameergoy@yahoo.com8890802830

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026